Wegovy Pill Still Dominating GLP-1 Market, Analysts Say
Wegovy continues to lead the U.S. GLP-1 market despite Eli Lilly's Foundayo launch. Investors are weighing uptake, pa...
An index aggregates price movement to summarize market direction, helping traders and investors gauge momentum and risk.
28,440 articlesWegovy continues to lead the U.S. GLP-1 market despite Eli Lilly's Foundayo launch. Investors are weighing uptake, pa...
Palo Alto Networks reports a milestone milestone: a $10B revenue run rate fueled by platform expansion and AI securit...
The U.S. IPO market is rekindling activity in 2026, with more offerings and steadier early trading as investors weigh...
Lam Research surged about 21% from its June trough as markets priced in a slower path for rate hikes. This report wei...
As summers heat up, teen summer employment headed for the weakest season since 1948, with job openings shrinking and ...
Markets are buzzing over signals from Elon Musk as SpaceX soars toward a trillion-dollar valuation and Musk tightens ...
Oil prices slide to the low $70s as Middle East risk cools, fueling debates on whether the Federal Reserve has paused...
A durable industrial leader with long-term contracts stands out as markets tilt toward defensives. Here’s why this in...
A free cash flow ETF is delivering a surprising edge in 2026, outperforming the S&P 500 as investors rotate toward ca...
NexaTech Holdings, a $40 billion market-cap company, raised its revenue guidance on stronger-than-expected demand, si...
Leveraged ETFs have surged toward $200 billion in assets under management, raising questions about how daily rebalanc...
JPMorgan Chase delivered a record quarterly performance, yet Jamie Dimon cautioned that the current market sprint cou...